Article

There's No Place Like Home: The Case For Repatriating The Pharmaceutical Supply Chain

By Paul Dupont, head of digital marketing, Pharmaceutics International, and Perry Rearick, owner, Mungadai Consulting and Marketing Co.

supply chain

This year has turned much of the world on its side as nations, communities, and businesses of all sizes reoriented and, in some cases, transformed themselves to an environment that included an unwelcome guest, COVID-19. Changes have included work-from-home initiatives, virtual tradeshows, cancelled conferences, zoom birthday parties, and travel restrictions. The ways we work, move, and interact with each other may never look the same.

Reacting to unexpected challenges by optimistically searching for the opportunities is something we all like to claim, but these challenges have been epic at times. We do not intend to diminish the pain the pandemic has beset on so many. However, the best way to honor the lives of those lost to COVID-19 is to find triumph in the tragedy of this virus. We think the pandemic has broadcast a loud call for bringing our nation’s pharmaceutical healthcare supply chain back to the United States.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Pharmaceutics International